“MuCovid-21” study: Mucormycosis at an Indian tertiary care centre during the COVID-19 pandemic

Background Mucormycosis has been reported in several Indian states with the second wave of COVID-19 from January 2021 onwards. This prospective study was conducted with the objective of defining the contribution or association of various known and many suspected factors in the incidence of this disease during the ongoing pandemic.